Rethinking Chronic Care: A $1.8M Push to Fix a Fragmented System

NASHVILLE, TN – June 24, 2026 – It's a quiet crisis unfolding in homes across America. More than half of all U.S. adults are now living with multiple chronic conditions, navigating a healthcare system that was never built for them. They juggle a dizzying array of specialists, conflicting medications, and redundant appointments, often with poor results and staggering costs. Now, a significant new investment aims to generate the proof needed to fix this broken model.

Monogram Health, a provider specializing in in-home, multi-specialty care, announced today it is committing $1.8 million to the University of Pennsylvania’s prestigious Leonard Davis Institute of Health Economics (Penn LDI). The three-year initiative isn't just a philanthropic gesture; it's a strategic effort to rigorously validate a different way of caring for the nation's most medically complex patients—one that brings integrated, continuous care out of the clinic and into the living room.

The Anatomy of a Broken System

For the millions of Americans managing conditions like heart failure, diabetes, and kidney disease simultaneously, the healthcare journey is often one of fragmentation. A 2025 CDC report highlighted that the share of Americans with multiple chronic conditions has climbed to over 51%, and the economic burden is immense. According to CMS data, Medicare beneficiaries with six or more chronic conditions account for a disproportionately high share of healthcare spending, driving costs and straining public programs.

The human cost is just as severe. Patients face a system that treats diseases in silos, not as interconnected challenges affecting a whole person. This leads to gaps in care, preventable hospitalizations, and a diminished quality of life.

“Patients dealing with more than one chronic condition often face a fragmented health care system that is not designed around the complexity of their needs,” said Dr. Rachel M. Werner, Executive Director of Penn LDI. This partnership, she noted, presents an opportunity “to produce rigorous evidence about how to better support these patients, improve care, and advance models of care that are more responsive, equitable, and effective.”

A Blueprint for In-Home Integration

This is the landscape Monogram Health aims to change. The Nashville-based company has built its model around a team-based approach that deploys nurse practitioners, physicians, specialists, pharmacists, and social workers directly to a patient's home. Instead of focusing on a single specialty, the teams provide comprehensive care, managing everything from medication and diagnostics to diet and access to transportation.

Early results from the company's work with over 66,000 patients suggest the model has promise. Monogram reports a 21.8% reduction in hospital readmissions and outcomes for hypertension and A1C control that surpass national averages. But in a healthcare industry driven by evidence, internal data is not enough. The partnership with Penn LDI is designed to provide the independent, academic validation needed to influence broader policy and practice.

The research will be multifaceted, examining how these home-based, multi-specialty models impact patient outcomes, overall costs, and the patient experience. One key area of study will be the effectiveness of an advanced practice provider-led model, where specialty-trained nurse practitioners and physician assistants deliver care supported by a central physician team and evidence-based protocols.

The Value-Based Imperative

This initiative arrives at a critical juncture for U.S. healthcare, as the entire system pivots from a fee-for-service model to value-based care, where payment is tied to patient outcomes, not the volume of procedures. The research funded by Monogram will directly inform this transition by exploring how payment reform affects care delivery.

Researchers at Penn LDI will investigate how different payment models, including the growing influence of Medicare Advantage plans, can either help or hinder innovation in at-home care. The goal is to provide a roadmap for creating sustainable financial structures that reward providers for keeping complex patients healthy and out of the hospital.

“As Americans continue to live longer, they will acquire more chronic illnesses as they age,” said Dr. Shaminder Gupta, Chief Medical Officer at Monogram Health. He emphasized that this research will provide “much needed insights for policymakers, healthcare payers, and providers alike, to help them address and prepare for the ever-changing landscape of longitudinal care in America.”

Building on a Foundation of Kidney Care

This new, broader research initiative builds upon a previous multi-year partnership between Monogram and Penn LDI that began in 2022. That initial $2.5 million program focused specifically on patients with chronic kidney disease (CKD), a population that exemplifies the challenges of complex care. The collaboration tested tangible interventions, including the use of community health workers, prescriptions for nutritious food, and home-based palliative care.

Crucially, that earlier work also tackled health equity, funding research to address racial disparities in CKD diagnosis and care—including efforts to remove the race-based modifier from kidney function calculations that has historically delayed care for African American patients. The new program will continue this focus on equity, with one of its three core pillars dedicated to studying engagement and equity considerations within value-based care.

The expansion from a single disease to the wider population of polychronic patients reflects a growing recognition that a holistic approach is necessary. While other companies have entered the in-home care space, the path to sustainability can be challenging, underscoring the need for the kind of rigorous, independent evidence this partnership seeks to produce. By academically validating what works, the collaboration aims to create a durable blueprint for a system that finally meets the complex needs of its most vulnerable patients.